Efficacy Evaluation of Wasabi Leaf Extract on Skin
Launched by TCI CO., LTD. · Mar 28, 2022
Trial Information
Current as of June 01, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 20 to 65-year-old males or females
- • People with dull skin, pigmentation spots or acne-prone, acne scars
- • Acne severity assessment- Investigator's Global Assessment Scale (IGA) ≥ 2
- Exclusion Criteria:
- • Received medical cosmetic treatment (including cosmetic skin care, laser, fruit acid peeling, injection or plastic surgery, etc.) currently or within one month before the trial
- • Outdoor workers (exposed to the sun more than 5 hours a day)
- • People who are breastfeeding, pregnant or planning to become pregnant during the test (self-report)
- • People with heart, liver, kidney, endocrine and other major organic diseases (self-reported)
- • People who have undergone major surgery (according to medical history)
- • People who take drugs for a long time
- • People with mental illness
- • Students who are currently taking courses taught by the principal investigator of this trial
About Tci Co., Ltd.
TCI Co., Ltd. is a pioneering clinical trial sponsor dedicated to advancing healthcare through innovative research and development. With a strong focus on improving patient outcomes, TCI Co., Ltd. specializes in designing and managing clinical trials across various therapeutic areas. The company is committed to adhering to the highest standards of regulatory compliance and ethical practices, ensuring the integrity and reliability of its studies. By leveraging cutting-edge technologies and a team of experienced professionals, TCI Co., Ltd. strives to contribute to the development of safe and effective medical treatments, ultimately enhancing the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taichung, , Taiwan
Patients applied
Trial Officials
Hsiu-Mei Chiang, Prof.
Principal Investigator
China Medical University, China
Po-Yuan Wu, Dr.
Study Director
China Medical University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials